Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Does risk stratification decrease the risk of natalizumab-associated PML? Where is the evidence?
Impact of diagnosis and early treatment on the course of multiple sclerosis.
Epstein-Barr virus Peptide Presented by HLA-E is Predominantly Recognized by CD8(bright) Cells in multiple Sclerosis Patients.
JC viremia in natalizumab-treated patients with multiple sclerosis.
Epitope spreading in immune-mediated diseases: implications for immunotherapy.
Historical Issues of Optic neuritis and Sensory Disorder in Persian Traditional Medicine.
Endogenous and recombinant type I interferons and disease activity in multiple sclerosis.
Tumor-like multiple sclerosis.
Low dose naltrexone therapy in multiple sclerosis.
A signal-to-noise-ratio-based analysis of multifocal visual-evoked potentials in multiple sclerosis risk assessment.
The benefits of exercise training in multiple sclerosis.
Naltrexone prescribing information
Erythropoietin for acute multiple sclerosis in patients with optic neuritis as a first demyelination event.
Pediatric multiple sclerosis in Venezuela.
Significance of Virchow-Robin Spaces in Patients Newly Diagnosed with Multiple Sclerosis: A Case-Control Study in an Arab Population.
Mobile phones and multiple sclerosis - a nationwide cohort study in denmark.
Extensive molluscum contagiosum virus infection in a young adult receiving fingolimod.
Presymptomatic diagnosis with MRI and adequate treatment ameliorate the outcome after natalizumab-associated progressive multifocal leukoencephalopathy.
Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions.
Multiple sclerosis and sexual dysfunction.
Is multiple sclerosis an autoimmune disease?
Risk of vascular disease in patients with multiple sclerosis: a review.
Sativex(®) in multiple sclerosis spasticity: a cost-effectiveness model.
Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience.
Riluzole (2-amino-6-trifluoromethoxy benzothiazole) attenuates MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.

Pages